These Are the 3 Biggest Bargains in Biotech

Source

Investing in 2020 hasn't been easy. We've watched the broad-based S&P 500 lose 34% of its value in under five weeks, then take less than five months to recoup all of its losses (and then some).

However, periods of heightened volatility often provide opportunities for long-term investors to scoop up shares of great businesses on the cheap. Since the March 23 low, investors have taken a particular liking to the technology sector, with cloud computing, cybersecurity, and artificial intelligence stocks rocketing higher.

But there's another group of stocks currently being overlooked by Wall Street that may offer incredible value and upside to patient investors: biotech stocks.

Although the vast majority of biotech stocks are losing money, a handful of these profitable drug developers are valued at levels that make them absolute bargains. I deem the following three to be the top bargains in the entire biotech industry.

A stethoscope placed atop a neatly fanned pile of one hundred dollar bills.

IMAGE SOURCE: GETTY IMAGES.

Exelixis

Exelixis (NASDAQ:EXEL), a longtime holding in my own portfolio and a company I've pounded the table on for years, is the perfect example of a high-growth and profitable biotech stock that's getting far too little respect on Wall Street.

The Exelixis story primarily revolves around Cabometyx, the company's lead cancer drug, which is approved to treat first-and-second-line renal cell carcinoma (RCC) and advanced hepatocellular carcinoma. In clinical studies, Cabometyx ran circles around Pfizer‘s previous first-line standard-of-care drug, Sutent, in RCC treatment. Cabometyx is still the only second-line RCC treatment to have generated the clinical trifecta of a statistically significant improvement in objective response rate, progression-free survival, and overall survival.

Based solely on these indications, Cabometyx should be able to top $1 billion in annual sales by next year, but it's nowhere near finished. Exelixis is testing Cabometyx in six dozen clinical studies as a monotherapy or combination therapy. Even a handful of these clinical studies proving successful could be a major win for Cabometyx's demand and Exelixis' pricing power on its lead drug.

It's worth noting that the CheckMate 9ER study, which combined Cabometyx with Bristol Myers Squibb‘s (NYSE:BMY) Opdivo, met its primary endpoint in first-line RCC and also reduced patient risk of death by 40%. It would appear that this combination therapy may allow Exelixis and Bristol Myers to secure a significant portion of first-line RCC revenue, if approved. 

The point is that Exelixis is expected to grow sales by a double-digit rate for the foreseeable future and is valued at a PEG ratio of just 0.7. Anything below 1 is typically viewed as “undervalued.” Also, it has a whopping $1.2 billion in cash, with the potential to generate $500 million in free cash flow each year.

How Exelixis is only worth $7.2 billion as of this past weekend is one of Wall Street's greatest mysteries.

A lab technician using a multi-pipette tool to fill test tubes with samples.

IMAGE SOURCE: GETTY IMAGES.

Jazz Pharmaceuticals

Another biotech stock that's been getting the Rodney Dangerfield treatment (i.e., getting no respect) is Ireland-headquartered Jazz Pharmaceuticals (NASDAQ:JAZZ).

The biggest knock against Jazz has always been the company's reliance on its blockbuster narcolepsy drug Xyrem. Approved 18 years ago, Xyrem is on track to account for roughly $1.7 billion of the company's forecasted $2.225 billion to $2.325 billion in full-year sales in 2020. Additionally, Xyrem finds itself in the spotlight every couple of years for the substantive price hikes that Jazz Pharmaceuticals has passed along. 

Yet for all of these concerns, Jazz and Xyrem keep delivering. With little in the way of serious competition, Jazz has ridden the coattails of its blockbuster drug to nearly 1,000% share price gains over the trailing 13 years. What's more, a politically divided Congress doesn't appear to be capable of real drug price reform. Investors tend to get jumpy when lawmakers discuss the idea of capping brand-name drug price hikes, but nothing substantive ever comes to fruition.

Beyond its tried-and-true narcolepsy treatment, Jazz is attempting to dazzle Wall Street with five imminent and/or upcoming drug launches. Arguably the most exciting of these is Xywav, a sister drug to Xyrem that contains 92% less sodium per nightly dose than its 2002-approved counterpart. Since Xyrem's sodium levels can cause problems for narcoleptic patients who also have heart issues, Xywav offers clinically proven efficacy with far less heart-associated risk. Xywav should launch sometime this quarter. 

Jazz Pharmaceuticals is a company capable of mid- to high-single-digit growth that has well-insulated cash flow and is valued at less than 9 times Wall Street's consensus adjusted earnings for 2021.

A lab researcher using a pipette to place samples under a high-powered microscope.

IMAGE SOURCE: GETTY IMAGES.

Alexion Pharmaceuticals

A final biotech bargain that investors should consider adding to their portfolios is Massachusetts-based Alexion Pharmaceuticals (NASDAQ:ALXN).

What sets Alexion apart from most other drug developers is the company's focus on ultra-rare diseases. We're talking about certain indications for which prospective patient pools may be measured in the hundreds. While there's a lot of risk that comes with targeting extremely rare indications, the reward can be incredible for treatments that succeed. In many indications, Alexion has little or no competition. Further, insurers are highly unlikely to push back on Alexion's list price since these patients have no other treatment alternatives.

Keeping with the theme here, Alexion has really leaned on one drug to drive its impressive sales growth. This drug, Soliris, is capable of roughly $4 billion in annual sales and has had its label expanded a number of times over the years.

But what's more exciting is Alexion's development of Ultomiris as a Soliris replacement. Ultomiris only needs to be administered once every eight weeks, as opposed to every two weeks with Soliris. This schedule improves patient quality of life. The development of Ultomiris also renders moot concerns about Soliris eventually losing patent exclusivity. As Ultomiris replaces Soliris over time, Alexion will have secured its cash flow for many years to come.

A combination of strong pricing power, internal innovation, and Alexion's addition of orphan therapies via acquisition should allow the company to maintain a low double-digit growth rate for the foreseeable future. That makes its forward price-to-earnings ratio of 9 exceptionally cheap.

Bonus: The #1 Biotech Stock For October

Big Pharma loves to buy small biotech's right after the market drops.

When the market dropped 19% in the fourth quarter of 2018, Ex-Wall Street CEO Dylan Jovine picked 3 biotech stocks ripe for a takeover.

On October 1st, 2018, he recommended Tesaro… 63 days later it was taken over for an easy 91% profit…

On October 19, 2018 he recommended Pacific Biosciences… 4 days later it was taken over for a quick 72% gain…

On January 4, 2019 he recommended Loxo Oncology… 3 days later it was taken over for a fast 71% gain…

Well guess what? The Coronavirus market drop has given Big Pharma its first takeover target of 2020.

In this special letter, you'll learn why Dylan thinks now is the best time to make money with this tiny stock.

You'll discover:

  • Why Big Pharma firms Allergan, Celgene and others have invested over $1 billion into this tiny biotech.
  • Why President Trump thinks this biotech's breakthrough is a matter of national security.
  • How a takeover could make you $41,250 in profits any day now.

That's because in this letter, we'll show you how get into this company right now – before it's too late!

You don't want to miss this.

Read this urgent letter now >>>

All Investors Should Be Watching This Stock

Enter your email below to get access to all the details on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

All Investors Should Be Watching This Stock

Enter your email below to get access to all the details on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

All Investors Should Be Watching This Stock

Enter your email below to get access to all the details on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

All Investors Should Be Watching This Stock

Enter your email below to get access to all the details on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

ELON’S FINAL MOVE

Elon’s new AI venture promises to create 10 TIMES MORE American millionaires than Tesla did.
Enter your email below to see the backdoor way to play Musk’s private AI startup…


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

All Investors Should Be Watching This Stock

Enter your email below to get access to all the details on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

All Investors Should Be Watching This Stock

Enter your email below to get access to all the details on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

FREE ACCESS TO CHAIKIN ANALYTICS

Marc Chaikin has developed a system  over the past 50 years…

A website that shows you which stocks could soon rise by 100% or more, by typing in any of 4,000 tickers.

Today, he’s allowing me to offer you free access to the system here, as part of a major new prediction he’s making.

Enter your email for access, and get his free recommendation.



By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

All Investors Should Be Watching This Stock

Enter your email below to get access to all the details on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

All Investors Should Be Watching This Stock

Enter your email below to get access to all the details on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write These 12 Stock Tickers Down Right Now

Enter your email below to see the stock names and tickers on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Investment Down Right Now

Enter your email below to see the name and ticker on the next page, and start collecting monthly payouts now.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Down Right Now

Enter your email below to see the name and ticker on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Ticker Down Right Now

Enter your email below to see the name and ticker on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the the stock name and ticker on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the the stock name and ticker on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the the stock name and ticker on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock's Name Down Right Now

A new ground-floor opportunity for 8,788% returns has emerged but you must act by December 31st…
Enter your email below to see the the stock name and ticker on the next page. 


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Write This Stock Ticker Down Right Now

Enter your email below to see the stock name and ticker on the next page.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

“The Forever Battery”

Secret Startup Cracks the Battery Code — Wall Street Legend Predicts a 1,500% Surge in Electric Car Sales Over the Next 4 Years…

Enter your email address to receive the name and ticker symbol of this once-in-a-lifetime investment opportunity.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

3 High-Yield Dividends for Guaranteed Passive Income

Here are the best dividend stocks for smart investors to secure a steady & reliable “second income”. Our top pick is trading for just $2.
Enter your email address for our free report.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

New EV Set to Disrupt Entire Industry

The Wall Street Journal calls it “an American manufacturing triumph.” It promises to revolutionize the driving experience and hand investors MASSIVE profits.
Enter your email address to receive the name & ticker symbol now.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Forget 99% of Tickers - Just Use This One

Larry Benedict is sharing a crazy over-the-shoulder “demo” (less than 10 seconds). Learn how to make all the money you need – in any market – using a single stock.
Enter your email address to watch now and get the name of the ticker you need to get started.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

Is Amazon Obligated to Pay You?

Thanks to a U.S. law, you can claim your slice of this jackpot and collect up to $48,000 over the next year.

Enter your email below to find out how.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

By submitting your email address, you give Today’s Top Stocks and Morning Bullets permission to deliver the report or research you’re requesting to your email inbox. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

#1 Energy Pick

This little-known Silicon Valley company is using AI to do something incredible…
Enter your email address to receive the name and ticker symbol of the #1 tech bargain stock now.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

By submitting your email address, you give Today’s Top Stocks and Morning Bullets permission to deliver the report or research you’re requesting to your email inbox. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

#1 EV Breakthrough of 2022

Louis Navellier is about to give away the ticker symbol of an overlooked battery company… one set to skyrocket in value as the EV boom gets underway. 
Simply enter your email below to learn the name of this company today…


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

By submitting your email address, you give Today’s Top Stocks and Morning Bullets permission to deliver the report or research you’re requesting to your email inbox. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Anyone can invest like “The People’s Shark” with as little as $100

You no longer have to be rich, famous, or powerful to become an angel investor. Starting now, it’s possible for you to get involved in these life-changing deals.
Enter your email address for all the details of this once-in-a-lifetime investment opportunity.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

By submitting your email address, you give Today’s Top Stocks and Morning Bullets permission to deliver the report or research you’re requesting to your email inbox. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Is L.A.S.E.R. The Greatest Tech Breakthrough in History?

A $3.5 trillion megatrend… spearheaded by Elon Musk is bringing what could be the most disruptive, revolutionary tech breakthrough the world has ever seen, with one small company sitting at the center.
Enter your email address to receive the name and ticker symbol of this once-in-a-lifetime investment opportunity.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

By submitting your email address, you give Today’s Top Stocks and Morning Bullets permission to deliver the report or research you’re requesting to your email inbox. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

2,467% Return on Israeli Laser Company

Learn the 3 Steps You Need to Protect Your Retirement and One Stock that Could Soar 2,476% in Nine Months.
Enter your email address to receive the name and ticker symbol of this once-in-a-lifetime investment opportunity.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

By submitting your email address, you give Today’s Top Stocks and Morning Bullets permission to deliver the report or research you’re requesting to your email inbox. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

One Tweet From Elon Could Blow This Story Wide Open

Last year, anyone who listened to this man about Tesla could’ve made EIGHT TIMES their money. Now he’s revealing how Elon’s NEXT big move will revolutionize ANOTHER massive $23 trillion market.
Enter your email address to receive the name and ticker symbol of this once-in-a-lifetime investment opportunity.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

By submitting your email address, you give Today’s Top Stocks and Morning Bullets permission to deliver the report or research you’re requesting to your email inbox. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

$25 to Profit from 20,000 IPOs

Days from now — 20,000 ‘IPOs’ could start flooding the market…
Enter your email address to reveal how anyone with $25 can stake their claim.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works

By submitting your email address, you give Today’s Top Stocks and Morning Bullets permission to deliver the report or research you’re requesting to your email inbox. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

"Bio-Chip" Sparks Potential 199,900% Surge by 2025

Sign up below for all the details on this tiny company being considered a once-in-a-lifetime investment opportunity.


By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works